We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

33 hedge funds and large institutions have $219M invested in Vigil Neuroscience in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

402% more capital invested

Capital invested by funds: $43.7M → $219M (+$175M)

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

25.51% more ownership

Funds ownership: 61.35% → 86.86% (+26%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

6% less funds holding

Funds holding: 35 → 33 (-2)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
33
Holders Change
-2
Holders Change %
-5.71%
% of All Funds
0.57%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
6
Increased
12
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$15.1M
2
DM
Deerfield Management
New York
+$15.1M
3
BI
BVF Inc
California
+$13.3M
4
AG
Artal Group
Luxembourg
+$8.54M
5
DCM
DAFNA Capital Management
California
+$855K

Top Sellers

Rank Fund Capital Flow
1
PI
PEAK6 Investments
Illinois
-$135K
2
Renaissance Technologies
Renaissance Technologies
New York
-$97K
3
LP
LMR Partners
United Kingdom
-$65K
4
PHK
Point72 Hong Kong
Hong Kong
-$31K
5
Morgan Stanley
Morgan Stanley
New York
-$23.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$53.1M – – –
NV
2
Northpond Ventures
Maryland
$38.4M – – –
DTC
3
Deep Track Capital
Connecticut
$21.5M +$15.1M +2,054,795 +666%
AG
4
Artal Group
Luxembourg
$20.8M +$8.54M +1,164,383 +104%
Citadel Advisors
5
Citadel Advisors
Florida
$19.7M +$10.5K +1,431 +0.1%
DM
6
Deerfield Management
New York
$18M +$15.1M +2,054,794 New
BI
7
BVF Inc
California
$16.5M +$13.3M +1,813,633 New
CAM
8
Cormorant Asset Management
Massachusetts
$5.61M – – –
PBPIA
9
Pivotal bioVenture Partners Investment Advisor
California
$5.1M – – –
RSCM
10
Rock Springs Capital Management
Maryland
$4.29M – – –
Vanguard Group
11
Vanguard Group
Pennsylvania
$3.33M +$82.3K +11,218 +3%
HMC
12
Harvard Management Company
Massachusetts
$2.63M – – –
DCM
13
DAFNA Capital Management
California
$1.97M +$855K +116,641 +117%
LGM
14
Logos Global Management
California
$1.87M – – –
LCM
15
Laurion Capital Management
New York
$1.19M – – –
Barclays
16
Barclays
United Kingdom
$929K +$3.54K +482 +0.5%
BlackRock
17
BlackRock
New York
$926K -$18.3K -2,498 -2%
Goldman Sachs
18
Goldman Sachs
New York
$665K -$389 -53 -0.1%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$653K +$89.3K +12,174 +20%
Citigroup
20
Citigroup
New York
$616K +$19K +2,592 +4%
E
21
Ergoteles
New York
$260K +$209K +28,533 New
Fidelity Investments
22
Fidelity Investments
Massachusetts
$245K +$197K +26,915 +67,288%
Adage Capital Partners
23
Adage Capital Partners
Massachusetts
$203K – – –
State Street
24
State Street
Massachusetts
$195K +$22K +3,000 +16%
ACM
25
Altium Capital Management
New York
$144K +$116K +15,788 New
1
2

VIGL Hedge Fund Activity: Q3 2022 in Review

33 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q3 2022, worth a combined $219M — up 402% from $43.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of VIGL and 6 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 12 added.

The largest buyer was Deep Track Capital, adding an estimated $15.1M. The largest seller was PEAK6 Investments, exiting entirely with an estimated $135K sold.

  • 33 institutional investors held Vigil Neuroscience (VIGL) as of Q3 2022, down from 35 in Q2 2022.
  • Funds reported $219M of Vigil Neuroscience stock for Q3 2022, up 402% quarter-over-quarter.
  • 6 funds opened new Vigil Neuroscience positions in Q3 2022 and 8 closed out, a net change of -2 holders.
  • The largest Vigil Neuroscience buyer in Q3 2022 was Deep Track Capital, an estimated $15.1M added.
  • The largest Vigil Neuroscience seller in Q3 2022 was PEAK6 Investments, an estimated $135K sold.

Based on aggregated 13F filings for Q3 2022.